London Regional Health Science Centre
London, Ontario, N6A 5A5, Canada
Location status: Recruiting
Location contact
Mark Chandy, MD, PhD
CONTACT
NCT Number: NCT05581368
Cannabis is commonly used globally. It is associated with psychiatric problems, but the effects on the cardiovascular system are unclear. In this project, the investigators plan to study the effects of cannabis on the cardiovascular system. This will be done by using a non-invasive test to measure blood vessel function and by using blood samples to measure inflammation. As a control for this project, the investigators would like to test the blood vessel function and inflammation levels of participants who do not use cannabis. This study will provide important information on the long term cardiovascular effects of cannabis.
Interested in participating?
Request Info19 year–80 year
All sexes
Observational
London, Ontario, N6A 5A5, Canada
Location status: Recruiting
Mark Chandy, MD, PhD
CONTACT
Cannabis is the most commonly used illicit drug in the world, but the investigators do not know the long-term effects on the cardiovascular system in humans. The investigators have data from cell culture and small animal studies that cannabis is toxic to the cardiovascular system. Recently legalized in Canada, the long-term effects of cannabis use on the cardiovascular system may not be apparent for several decades. The purpose of this study is to test the effect of cannabis use on the vascular system. Using a non-invasive test of vascular function, the investigators would like to assess the effects of cannabis on chronic cannabis users. The investigators would also like to test if cannabis use by smoking and/or vaping causes adverse cardiovascular effects acutely. Lastly, the investigators would like to test blood from chronic cannabis users for inflammatory cytokines, which could further support our hypothesis that cannabis damages the cardiovascular system via inflammation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The investigators will test levels of inflammation and vascular dysfunction in participants who chronically use cannabis.
Time frame: Baseline measurement.
The investigators will measure the concentration of inflammatory cytokines using an Olink for chronic cannabis users and the control group.
Time frame: Baseline measurement.
The investigators will measure the reactive hyperaemia index (RHI) using an EndPAT device for both groups.
Time frame: Baseline measurement.
The investigators will measure lipid profile (total cholesterol, LDL, HDL, ratio) for both groups.
Time frame: Baseline measurement.
The investigators will measure body-mass index or both groups.
Time frame: Baseline measurement.
The investigators will measure baseline blood pressure for both groups.
Contact information is provided by the study sponsor or research team.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Other
Elucidating the Effects of Cannabis on Cardiovascular System
Acronym: SECV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04181996
Arterial Occlusive Diseases, Arteriosclerosis
Edmonton, Alberta, Canada
View Trial DetailsNCT00046605
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT00006403
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT00318734
Arterial Occlusive Diseases, Arteriosclerosis
Chapel Hill, North Carolina, United States
View Trial Details